PUBLISHER: Inkwood Research | PRODUCT CODE: 1069196
PUBLISHER: Inkwood Research | PRODUCT CODE: 1069196
The Europe biomaterials market is estimated to rise with a CAGR of 12.62% during the forecast period, 2022-2030. The market growth is expected to be driven by technological transformations and changing healthcare ecosystems with the adoption of advanced and effective technologies.
The Europe biomaterials market growth evaluation entails the assessment of Italy, Russia, United Kingdom, Belgium, France, Poland, Germany, and Rest of Europe. In France, various organizations focus on researching biomaterial implants and tissue engineering. Moreover, the increasing geriatric population, the surge in prevalence of chronic diseases, and the presence of various research organizations are found to increase the demand for biomaterials in the region.
Furthermore, the Italy biomaterials market growth is stimulated by increasing demand from orthopedic, cardiovascular, ophthalmology, wound healing, dental, plastic surgery, tissue engineering, and neurological & central nervous system. However, the regional market lacks the presence of key players. But with increased funding and the rising interest in adopting cosmetic procedures, the biomaterials market is expected to grow in Italy.
In addition, Russia represents a very attractive market for developing biomaterials, given its extensive renewable energy assets and country-wide range of consumers. Major players operating in Russia are banking upon aggressive marketing and innovations strategies to cater to a wide range of consumers operating in the region. The improved socio-economic conditions and the modernization of consumption patterns in Russia are also anticipated to propel the demand for biomaterials in the country.
Some prominent market players in the market include: Noble Biomaterials Inc, Royal DSM, BASF, Mitsubishi Chemical Holdings Corporation, Covestro AG, Collagen Solutions PLC, Zimmer Biomet Holdings Inc, etc.